BlueCrest Capital Management’s Reviva Pharmaceuticals Holdings, Inc. Warrants RVPHW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,251,250
| Closed | -$239K | – | 165 |
|
|
2022
Q3 | $239K | Buy |
1,251,250
+16,250
| +1% | +$3.1K | 0.01% | 124 |
|
|
2022
Q2 | $222K | Buy |
1,235,000
+14,400
| +1% | +$2.59K | 0.01% | 133 |
|
|
2022
Q1 | $333K | Hold |
1,220,600
| – | – | 0.01% | 190 |
|
|
2021
Q4 | $427K | Hold |
1,220,600
| – | – | 0.01% | 225 |
|
|
2021
Q3 | $488K | Hold |
1,220,600
| – | – | 0.01% | 262 |
|
|
2021
Q2 | $620K | Hold |
1,220,600
| – | – | 0.01% | 379 |
|
|
2021
Q1 | $561K | Hold |
1,220,600
| – | – | 0.01% | 522 |
|
|
2020
Q4 | $824K | Hold |
1,220,600
| – | – | 0.02% | 275 |
|
|
2020
Q3 | $623K | Hold |
1,220,600
| – | – | 0.02% | 203 |
|
|
2020
Q2 | $574K | Buy |
1,220,600
+400,000
| +49% | +$188K | 0.03% | 157 |
|
|
2020
Q1 | $74K | Buy |
820,600
+216,100
| +36% | +$19.5K | 0.01% | 162 |
|
|
2019
Q4 | $151K | Hold |
604,500
| – | – | 0.01% | 336 |
|
|
2019
Q3 | $151K | Hold |
604,500
| – | – | 0.01% | 498 |
|
|
2019
Q2 | $127K | Hold |
604,500
| – | – | 0.01% | 360 |
|
|
2019
Q1 | $97K | Buy |
604,500
+254,500
| +73% | +$40.8K | ﹤0.01% | 1072 |
|
|
2018
Q4 | $116K | Buy |
+350,000
| New | +$116K | 0.01% | 735 |
|